To examine the changes occurring with the combination therapy on both local and systemic level, we analysed the effect of NDV-ICOSL and CTLA-4 blockade on the TILs from the treated tumours and on the splenic T-cell populations (Fig. 6; Supplementary Figs 9 and 10). Here, ICOSLG is linked to neoplasm.